Search
Skip to Search Results
Filter
Subject / Keyword
Departments
Author / Creator / Contributor
Year
Collections
Languages
Item type
Supervisors
-
Spring 2017
BCR-ABL fusion oncogene is the main driver mutation of Chronic Myeloid Leukemia (CML) that controls initiation, maintenance and progression to more aggressive stages of the disease. Current therapies with tyrosine kinase inhibitors in CML involve certain limitations, such as drug resistance and...
1 - 1 of 1